Weight loss was significant in outcome trials, ranging from a 0.6 kg reduction at 12 weeks in the ELIXA trial to a 4.3 kg reduction at 2 years with injectable semaglutide in the SUSTAIN-6 trial
However, healthcare providers often recommend using the lowest effective dose for the shortest duration possible, as long-term use of PPIs carries its own set of considerations
Patients can expect no-obligation consultations to explore tailored solutions for effective weight management
Refunds are generally processed upon receipt of returned product(s), minus any applicable shipping costs
A 2022 study in Diabetes, Obesity and Metabolism (Friedrichsen et al.) measured voluntary fluid intake in semaglutide patients vs controls and found a 22% reduction in daily water consumption during the first 12 weeks
MacGregor AJ, Snieder H, Schork NJ, Spector TD